4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-25-241472
Chief Executive Officer sold 10,916 shares at an average $25.81 ($281,729)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/ownership.xml…